GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Enterprise Value

Vilin Bio Med (NSE:VILINBIO) Enterprise Value : ₹254.97 Mil (As of May. 21, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vilin Bio Med's Enterprise Value is ₹254.97 Mil. Vilin Bio Med's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹14.21 Mil. Therefore, Vilin Bio Med's EV-to-EBIT ratio for today is 17.95.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vilin Bio Med's Enterprise Value is ₹254.97 Mil. Vilin Bio Med's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹14.97 Mil. Therefore, Vilin Bio Med's EV-to-EBITDA ratio for today is 17.03.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Vilin Bio Med's Enterprise Value is ₹254.97 Mil. Vilin Bio Med's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹76.46 Mil. Therefore, Vilin Bio Med's EV-to-Revenue ratio for today is 3.33.


Vilin Bio Med Enterprise Value Historical Data

The historical data trend for Vilin Bio Med's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Enterprise Value Chart

Vilin Bio Med Annual Data
Trend Mar20 Mar21 Mar22
Enterprise Value
- - -

Vilin Bio Med Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Sep23
Enterprise Value - - - - 291.24

Competitive Comparison of Vilin Bio Med's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vilin Bio Med's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's Enterprise Value falls into.



Vilin Bio Med Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Vilin Bio Med's Enterprise Value for the fiscal year that ended in Mar. 2022 is calculated as

Vilin Bio Med's Enterprise Value for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vilin Bio Med  (NSE:VILINBIO) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Vilin Bio Med's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=254.968/14.208
=17.95

Vilin Bio Med's current Enterprise Value is ₹254.97 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vilin Bio Med's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹14.21 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Vilin Bio Med's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=254.968/14.97
=17.03

Vilin Bio Med's current Enterprise Value is ₹254.97 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vilin Bio Med's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹14.97 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Vilin Bio Med's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=254.968/76.457
=3.33

Vilin Bio Med's current Enterprise Value is ₹254.97 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Vilin Bio Med's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹76.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vilin Bio Med Enterprise Value Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vilin Bio Med (NSE:VILINBIO) Business Description

Traded in Other Exchanges
N/A
Address
Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009
Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines